Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors

REFERENCES

• Aberle, H., A. Bauer, J. Stappert, A. Kispert, and R. Kemler. 1997. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16: 3797–3804.
   PubMed Web of Science ®Google Scholar
• Behrens, J. 2000. Control of beta-catenin signaling in tumor development. Ann. N. Y. Acad. Sci. 910: 21–33.
   PubMed Web of Science ®Google Scholar
• Behrens, J., B. A. Jerchow, M. Wurtele, J. Grimm, C. Asbrand, R. Wirtz, M. Kuhl, D. Wedlich, and W. Birchmeier. 1998. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596–599.
   PubMed Web of Science ®Google Scholar
• Behrens, J., M. M. Mareel, F. M. Van Roy, and W. Birchmeier. 1989. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108: 2435–2447.
   PubMed Web of Science ®Google Scholar
• Behrens, J., J. P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638–642.
   PubMed Web of Science ®Google Scholar
• Bienz, M., and H. Clevers. 2000. Linking colorectal cancer to Wnt signaling. Cell 103: 311–320.
   PubMed Web of Science ®Google Scholar
• Brinkmann, V., H. Foroutan, M. Sachs, K. M. Weidner, and W. Birchmeier. 1995. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J. Cell Biol. 131: 1573–1586.
   PubMed Web of Science ®Google Scholar
• Cadigan, K. M., and R. Nusse. 1997. Wnt signaling: a common theme in animal development. Genes Dev. 11: 3286–3305.
   PubMed Web of Science ®Google Scholar
• Crawford, H. C., B. M. Fingleton, L. A. Rudolph-Owen, K. J. Goss, B. Rubinfeld, P. Polakis, and L. M. Matrisian. 1999. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883–2891.
   PubMed Web of Science ®Google Scholar
• Frixen, U. H., J. Behrens, M. Sachs, G. Eberle, B. Voss, A. Warda, D. Lochner, and W. Birchmeier. 1991. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113: 173–185.
   PubMed Web of Science ®Google Scholar
• Furuhashi, M., K. Yagi, H. Yamamoto, Y. Furukawa, S. Shimada, Y. Nakamura, A. Kikuchi, K. Miyazono, and M. Kato. 2001. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol. Cell. Biol. 21: 5132–5141.
   PubMed Web of Science ®Google Scholar
• Giarre, M., M. V. Semenov, and A. M. Brown. 1998. Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types. Ann. N. Y. Acad. Sci. 857: 43–55.
   PubMedGoogle Scholar
• Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M. M. Taketo. 1999. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18: 5931–5942.
   PubMed Web of Science ®Google Scholar
• Hart, M. J., R. de los Santos, I. N. Albert, B. Rubinfeld, and P. Polakis. 1998. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr. Biol. 8: 573–581.
   PubMed Web of Science ®Google Scholar
• He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
   PubMed Web of Science ®Google Scholar
• Herter, P., C. Kuhnen, K. M. Muller, A. Wittinghofer, and O. Muller. 1999. Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps. J. Cancer Res. Clin. Oncol. 125: 297–304.
   PubMedGoogle Scholar
• Hogan, B., R. Beddington, F. Costantini, and E. Lacey. 1994. Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
   Google Scholar
• Huber, O., R. Korn, J. McLaughlin, M. Ohsugi, B. G. Herrmann, and R. Kemler. 1996. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59: 3–10.
   PubMed Web of Science ®Google Scholar
• Huelsken, J., R. Vogel, V. Brinkmann, B. Erdmann, C. Birchmeier, and W. Birchmeier. 2000. Requirement for beta-catenin in anterior-posterior axis formation in mice. J. Cell Biol. 148: 567–578.
   PubMed Web of Science ®Google Scholar
• Hugh, T. J., S. A. Dillon, G. O'Dowd, B. Getty, M. Pignatelli, G. J. Poston, and A. R. Kinsella. 1999. Beta-catenin expression in primary and metastatic colorectal carcinoma. Int. J. Cancer 82: 504–511.
   PubMed Web of Science ®Google Scholar
• Ikeda, S., S. Kishida, H. Yamamoto, H. Murai, S. Koyama, and A. Kikuchi. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 17: 1371–1384.
   PubMed Web of Science ®Google Scholar
• Itoh, K., A. Antipova, M. J. Ratcliffe, and S. Sokol. 2000. Interaction of Dishevelled and Xenopus Axin-related protein is required for Wnt signal transduction. Mol. Cell. Biol. 20: 2228–2238.
   PubMedGoogle Scholar
• Jeng, Y. M., M. Z. Wu, T. L. Mao, M. H. Chang, and H. C. Hsu. 2000. Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett. 152: 45–51.
   PubMedGoogle Scholar
• Jho, E.-h., T. Zhang, C. Domon, C.-K. Joo, J.-N. Freund, and F. Costantini. 2002. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22: 1172–1183.
   PubMed Web of Science ®Google Scholar
• Kirchner, T., and T. Brabletz. 2000. Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am. J. Pathol. 157: 1113–1121.
   PubMedGoogle Scholar
• Koch, A., D. Denkhaus, S. Albrecht, I. Leuschner, D. von Schweinitz, and T. Pietsch. 1999. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 59: 269–273.
   PubMed Web of Science ®Google Scholar
• Korinek, V., N. Barker, P. J. Morin, D. van Wichen, R. de Weger, K. W. Kinzler, B. Vogelstein, and H. Clevers. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784–1787.
   PubMed Web of Science ®Google Scholar
• Li, L., H. Yuan, C. D. Weaver, J. Mao, G. H. Farr III, D. J. Sussman, J. Jonkers, D. Kimelman, and D. Wu. 1999. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 18: 4233–4240.
   PubMed Web of Science ®Google Scholar
• Li, L., H. Yuan, W. Xie, J. Mao, A. M. Caruso, A. McMahon, D. J. Sussman, and D. Wu. 1999. Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J. Biol. Chem. 274: 129–134.
   PubMed Web of Science ®Google Scholar
• Liu, W., X. Dong, M. Mai, R. S. Seelan, K. Taniguchi, K. K. Krishnadath, K. C. Halling, J. M. Cunningham, L. A. Boardman, C. Qian, E. Christensen, S. S. Schmidt, P. C. Roche, D. I. Smith, and S. N. Thibodeau. 2000. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 26: 146–147.
   PubMed Web of Science ®Google Scholar
• Molenaar, M., M. van de Wetering, M. Oosterwegel, J. Peterson-Maduro, S. Godsave, V. Korinek, J. Roose, O. Destree, and H. Clevers. 1996. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86: 391–399.
   PubMed Web of Science ®Google Scholar
• Morin, P. J., A. B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, and K. W. Kinzler. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787–1790.
   PubMed Web of Science ®Google Scholar
• Paulsen, J. E., I. L. Steffensen, E. M. Loberg, T. Husoy, E. Namork, and J. Alexander. 2001. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res. 61: 5010–5015.
   PubMedGoogle Scholar
• Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14: 1837–1851.
   PubMed Web of Science ®Google Scholar
• Roose, J., G. Huls, M. van Beest, P. Moerer, K. van der Horn, R. Goldschmeding, T. Logtenberg, and H. Clevers. 1999. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285: 1923–1926.
   PubMed Web of Science ®Google Scholar
• Rousset, R., J. A. Mack, K. A. Wharton, Jr., J. D. Axelrod, K. M. Cadigan, M. P. Fish, R. Nusse, and M. P. Scott. 2001. Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes Dev. 15: 658–671.
   PubMedGoogle Scholar
• Salic, A., E. Lee, L. Mayer, and M. W. Kirschner. 2000. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol. Cell 5: 523–532.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
   Google Scholar
• Samowitz, W. S., M. D. Powers, L. N. Spirio, F. Nollet, F. van Roy, and M. L. Slattery. 1999. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res. 59: 1442–1444.
   PubMed Web of Science ®Google Scholar
• Satoh, S., Y. Daigo, Y. Furukawa, T. Kato, N. Miwa, T. Nishiwaki, T. Kawasoe, H. Ishiguro, M. Fujita, T. Tokino, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, Y. Yamaoka, and Y. Nakamura. 2000. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24: 245–250.
   PubMed Web of Science ®Google Scholar
• Seidensticker, M. J., and J. Behrens. 2000. Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta 1495: 168–182.
   PubMed Web of Science ®Google Scholar
• Shih, I. M., T. L. Wang, G. Traverso, K. Romans, S. R. Hamilton, S. Ben-Sasson, K. W. Kinzler, and B. Vogelstein. 2001. Top-down morphogenesis of colorectal tumors. Proc. Natl. Acad. Sci. USA 98: 2640–2645.
   PubMed Web of Science ®Google Scholar
• Spiegelman, V. S., T. J. Slaga, M. Pagano, T. Minamoto, Z. Ronai, and S. Y. Fuchs. 2000. Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol. Cell 5: 877–882.
   PubMed Web of Science ®Google Scholar
• Su, L. K., K. W. Kinzler, B. Vogelstein, A. C. Preisinger, A. R. Moser, C. Luongo, K. A. Gould, and W. F. Dove. 1992. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668–670.
   PubMed Web of Science ®Google Scholar
• Terris, B., P. Pineau, L. Bregeaud, D. Valla, J. Belghiti, P. Tiollais, C. Degott, and A. Dejean. 1999. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 18: 6583–6588.
   PubMedGoogle Scholar
• Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426.
   PubMed Web of Science ®Google Scholar
• van de Wetering, M., R. Cavallo, D. Dooijes, M. van Beest, J. van Es, J. Loureiro, A. Ypma, D. Hursh, T. Jones, A. Bejsovec, M. Peifer, M. Mortin, and H. Clevers. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789–799.
   PubMed Web of Science ®Google Scholar
• Vasicek, T. J., L. Zeng, X. J. Guan, T. Zhang, F. Costantini, and S. M. Tilghman. 1997. Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 147: 777–786.
   PubMed Web of Science ®Google Scholar
• Wharton, K. A., Jr., G. Zimmermann, R. Rousset, and M. P. Scott. 2001. Vertebrate proteins related to Drosophila Naked Cuticle bind Dishevelled and antagonize Wnt signaling. Dev. Biol. 234: 93–106.
   PubMedGoogle Scholar
• Yamamoto, H., S. Kishida, T. Uochi, S. Ikeda, S. Koyama, M. Asashima, and A. Kikuchi. 1998. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3β and β-catenin and inhibits axis formation of Xenopus embryos. Mol. Cell. Biol. 18: 2867–2875.
   PubMedGoogle Scholar
• Yan, D., J. B. Wallingford, T. Q. Sun, A. M. Nelson, C. Sakanaka, C. Reinhard, R. M. Harland, W. J. Fantl, and L. T. Williams. 2001. Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd. Proc. Natl. Acad. Sci. USA 98: 3802–3807.
   PubMed Web of Science ®Google Scholar
• Zeng, L., F. Fagotto, T. Zhang, W. Hsu, T. J. Vasicek, W. L. Perry III, J. J. Lee, S. M. Tilghman, B. M. Gumbiner, and F. Costantini. 1997. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181–192.
   PubMed Web of Science ®Google Scholar